PAAM Hybrid 2023
BackOAS3: ENT, asthma and respiratory allergy
Friday 03 Nov, 13:45 PM -
15:15 PM Porto/Portugal (CET -1)
Porto Hall
Oral Abstract Session
13:45
Lung Function Responder Rates in the VOYAGE study in Children with Moderate-to-Severe Type 2 Asthma Receiving Dupilumab at Week 52
Abstract Text
13:57
Developing a quality of life outcome measure for paediatric severe asthma: a qualitative study
Abstract Text
14:09
SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma
Abstract Text
14:21
Respiratory allergy screening using skin prick test in primary care centers. Cost-benefit study in our area
Abstract Text
14:33
Current Transition Perspectives and Practice Of Adolescents And Young Adults With Allergy And/or Asthma: A European Survey in 2023
Abstract Text
14:45
Sensitization to pollens molecular allergens in the Portuguese pediatric population - national multicentric study
